Cargando…

A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury

Detalles Bibliográficos
Autores principales: Memon, Aliza A., Ahmed, Hasban, Li, Yi, Wongboonsin, Janewit, Hundert, Joshua, Benoit, Stefanie, Chaudhari, Advika, Sher, Jawad, Ghimire, Pratima, Hopkins, Rebecca, Patel, Jay, Stegman, Melinda, Lim, Kenneth, Azzi, Jamil, Siedlecki, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465494/
https://www.ncbi.nlm.nih.gov/pubmed/36120390
http://dx.doi.org/10.1016/j.ekir.2022.09.003
_version_ 1784787810688958464
author Memon, Aliza A.
Ahmed, Hasban
Li, Yi
Wongboonsin, Janewit
Hundert, Joshua
Benoit, Stefanie
Chaudhari, Advika
Sher, Jawad
Ghimire, Pratima
Hopkins, Rebecca
Patel, Jay
Stegman, Melinda
Lim, Kenneth
Azzi, Jamil
Siedlecki, Andrew M.
author_facet Memon, Aliza A.
Ahmed, Hasban
Li, Yi
Wongboonsin, Janewit
Hundert, Joshua
Benoit, Stefanie
Chaudhari, Advika
Sher, Jawad
Ghimire, Pratima
Hopkins, Rebecca
Patel, Jay
Stegman, Melinda
Lim, Kenneth
Azzi, Jamil
Siedlecki, Andrew M.
author_sort Memon, Aliza A.
collection PubMed
description
format Online
Article
Text
id pubmed-9465494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94654942022-09-12 A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury Memon, Aliza A. Ahmed, Hasban Li, Yi Wongboonsin, Janewit Hundert, Joshua Benoit, Stefanie Chaudhari, Advika Sher, Jawad Ghimire, Pratima Hopkins, Rebecca Patel, Jay Stegman, Melinda Lim, Kenneth Azzi, Jamil Siedlecki, Andrew M. Kidney Int Rep Research Letter Elsevier 2022-09-12 /pmc/articles/PMC9465494/ /pubmed/36120390 http://dx.doi.org/10.1016/j.ekir.2022.09.003 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Memon, Aliza A.
Ahmed, Hasban
Li, Yi
Wongboonsin, Janewit
Hundert, Joshua
Benoit, Stefanie
Chaudhari, Advika
Sher, Jawad
Ghimire, Pratima
Hopkins, Rebecca
Patel, Jay
Stegman, Melinda
Lim, Kenneth
Azzi, Jamil
Siedlecki, Andrew M.
A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
title A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
title_full A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
title_fullStr A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
title_full_unstemmed A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
title_short A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
title_sort randomized control trial of ravulizumab for treatment of patients with covid-19 infection and kidney injury
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465494/
https://www.ncbi.nlm.nih.gov/pubmed/36120390
http://dx.doi.org/10.1016/j.ekir.2022.09.003
work_keys_str_mv AT memonalizaa arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT ahmedhasban arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT liyi arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT wongboonsinjanewit arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT hundertjoshua arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT benoitstefanie arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT chaudhariadvika arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT sherjawad arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT ghimirepratima arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT hopkinsrebecca arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT pateljay arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT stegmanmelinda arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT limkenneth arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT azzijamil arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT siedleckiandrewm arandomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT memonalizaa randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT ahmedhasban randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT liyi randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT wongboonsinjanewit randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT hundertjoshua randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT benoitstefanie randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT chaudhariadvika randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT sherjawad randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT ghimirepratima randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT hopkinsrebecca randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT pateljay randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT stegmanmelinda randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT limkenneth randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT azzijamil randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury
AT siedleckiandrewm randomizedcontroltrialofravulizumabfortreatmentofpatientswithcovid19infectionandkidneyinjury